OMDA Omada Health, Inc.

P/E 36.84
Forward P/E 303.03
Price/Sales 4.514
Beta --
Div Yield --
Market Cap --

Company Analysis

Latest News

BlackRock Buys $48.8 Million Omada Health Stake, Signaling Institutional Confidence

BlackRock Buys $48.8 Million Omada Health Stake, Signaling Institutional Confidence

BlackRock Inc. acquired 2,222,074 shares of Omada Health, Inc. during the second quarter. The asset management firm disclosed the new position in a Form 13F...

πŸ”΄ Omada Health is trading 5% down today as macro pressures weigh on U.S. equities

Omada Health is trading at $23.32, down -5.01%, primarily as macro pressures weigh on U.S. equities. β€’ No fresh company-specific announcement was identified...

🟒 Omada Health is trading 6.84% up today in after-hours trading with Nasdaq Composite up 0.57%

Omada Health is trading 6.84% up at $25.60 in after-hours trading, with broader technology sentiment a possible support. - Nasdaq Composite is up 0.57%, but...

πŸ”΄ Omada Health is trading 5% down today amid likely profit-taking

Omada Health is trading 5.12% down now at $23.71, with profit-taking the most likely explanation. - Shares rose 5.58% on August 10 and 21.14% on August 7. -...

🟒 Omada Health is trading 5% up today after record revenue and higher 2026 guidance

Omada Health is trading 5% up at $24.86 after investors continued responding to the August 6 earnings report, which delivered record $88 million revenue,...

Omada Health Posts Record Profit and Raises Guidance β€” But Can a $1.3 Billion Digital Health Company Sustain 43% Growth Under New Leadership?

Omada Health Posts Record Profit and Raises Guidance β€” But Can a $1.3 Billion Digital Health Company Sustain 43% Growth Under New Leadership?

Shares of Omada Health surged 8.5% to $21.20 after the virtual chronic-care provider delivered its strongest quarter ever, pairing a blowout earnings beat with...

🟒 Omada Health is trading 18.73% up today after a Q2 revenue beat and raised 2026 guidance

Omada Health is trading $23.25 (+18.73%) after its August 6, 2026 earnings release showed a Q2 revenue beat and raised 2026 guidance. - Q2 revenue reached...

🟒 Omada Health is trading 8.5% up in pre-market after first GAAP-profitable quarter

Omada Health is trading 8.5% up at $21.20 after its August 6, 2026 earnings report delivered $87.8 million in revenue, record margins, and its first...

🟒 Omada Health is trading 6.4% up in after-hours trading after Q2 revenue beat consensus estimates

Omada Health is trading 6.4% up at $20.78 after reporting second-quarter revenue of $87.8 million, above the $80.0 million consensus estimate. - Revenue rose...

Omada Health’s second quarter 2026 revenue of $87.8M beat estimates by 10% amid record margins

Omada Health’s second quarter 2026 revenue of $87.8M beat estimates by 10% amid record margins

Omada Health reported a significant second quarter 2026 beat, posting its first period of GAAP profitability. Revenue grew 43% year-over-year to $87.8 million,...

πŸ”΄ Omada Health is trading 5.1% down today as investors position ahead of Q2 earnings

Omada Health is trading 5.1% down at $19.16 as investors position themselves ahead of its Q2 2026 earnings report scheduled for August 06, 2026. β€’ The...

Omada Health, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026

Analyst consensus points to Q2 2026 revenue of $80.0 million and an EPS of -$0.01, while the current stock price of $20.51 trades significantly below the...

πŸ”΄ Omada Health is trading 5.2% down today amid general market volatility and profit-taking

Omada Health is trading at $19.50 (5.2% down) with no fresh company-specific news or major announcements identified that directly explain the move. β€’ The...

πŸ”΄ Omada Health is trading 6% down today in a potential profit-taking reversal

Omada Health is trading at approximately $22.35 (6% down) in pre-market action, pulling back from its recent close despite a supportive analyst backdrop. β€’...

Omada Health Earns Buy Rating, $30 Target as Profitability Nears

Omada Health Earns Buy Rating, $30 Target as Profitability Nears

BTIG Research initiated coverage on Omada Health, Inc. with a Buy rating. The firm established a price target of $30 per share. Analysts expect the digital...

Omada Health insiders sell $3.2 million, clashing with bullish analyst outlooks

Omada Health insiders sell $3.2 million, clashing with bullish analyst outlooks

Omada Health filings from July 9, 2026, reveal that top executives sold over $3.2 million in company stock. The CEO, CFO, and CAO completed these transactions...